Sedec is focused on innovative therapeutics to modulate the immune cell system in autoimmune diseases and cancer immunotherapies. By centering our technology on the protein palmitoylation/depalmitoylation pathway, Sedec’s mission is to translate our unique biological breakthrough into a new generation of therapeutics for patients.
Company Details
- Employees
- 1
- Founded
- 2021
- Address
- 21 Strathmore Road, Natick,ma 01760,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.sedectx.com
- HQ
- Natick, MA
Sedec Therapeutics Questions
Sedec Therapeutics's website is http://www.sedectx.com
Sedec Therapeutics's LinkedIn profile is https://www.linkedin.com/company/sedectx
Sedec Therapeutics has
1 employees.
View email and phone details for 1
employees at Sedec Therapeutics.
Sedec Therapeutics's industry is
Biotechnology Research
Sedec Therapeutics's top competitors are
Akoya Biosciences, Inc.,
Ultima Genomics,
Gate Bioscience,
Cephla,
Stellaromics Inc.,
Unravel Biosciences,
Element Biosciences,
Vizgen,
Plaisance Capital Management Llc,
Elevatebio.
Sedec Therapeutics's categories are Biotechnology Research
Sedec Therapeutics's founding year is 2021
